December 14th, 2009

Research Led by Co-founders of aTyr Pharma Illustrates Mechanism for Multifunctionality of a Single Protein
Read More »

October 14th, 2009

Dr. Floyd Bloom Joins aTyr Pharma's Scientific Advisory Board
Read More »

aTyr Pharma, Inc. is a biopharmaceutical company focused on the discovery of an entirely new class of biologics.

aTyr Pharma’s discovery engine for new biotherapeutics consists of novel proteins in the family of tRNA synthetases with cell signaling activities distinct from the protein synthesis activities commonly associated with the tRNA synthetases. These proteins are being developed as novel therapeutics to treat cancer, neurodegenerative diseases, inflammation, cardiovascular diseases and metabolic disorders.